Detalhe da pesquisa
1.
Concurrent chemoradiotherapy followed by adjuvant cisplatin-gemcitabine versus cisplatin-fluorouracil chemotherapy for N2-3 nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial.
Lancet Oncol
; 24(7): 798-810, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37290468
2.
Deep learning signatures reveal multiscale intratumor heterogeneity associated with biological functions and survival in recurrent nasopharyngeal carcinoma.
Eur J Nucl Med Mol Imaging
; 49(8): 2972-2982, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35471254
3.
Prognostic significance of AKR1C4 and the advantage of combining EBV DNA to stratify patients at high risk of locoregional recurrence of nasopharyngeal carcinoma.
BMC Cancer
; 22(1): 880, 2022 Aug 11.
Artigo
Inglês
| MEDLINE | ID: mdl-35953777
4.
Establishment and validation of a recursive partitioning analysis based prognostic model for guiding re-radiotherapy in locally recurrent nasopharyngeal carcinoma patients.
Radiother Oncol
; 168: 61-68, 2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-35101468
5.
Association of Treatment Advances With Survival Rates in Pediatric Patients With Nasopharyngeal Carcinoma in China, 1989-2020.
JAMA Netw Open
; 5(3): e220173, 2022 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35234882
6.
Identifying distinct risks of treatment failure in nasopharyngeal carcinoma: Study based on the dynamic changes in peripheral blood lymphocytes, monocytes, N classification, and plasma Epstein-Barr virus DNA.
Head Neck
; 44(1): 34-45, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34636116
7.
Deintensified Chemoradiotherapy for Pretreatment Epstein-Barr Virus DNA-Selected Low-Risk Locoregionally Advanced Nasopharyngeal Carcinoma: A Phase II Randomized Noninferiority Trial.
J Clin Oncol
; 40(11): 1163-1173, 2022 04 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34990291
8.
Induction or adjuvant chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in paediatric nasopharyngeal carcinoma in the IMRT era: A recursive partitioning risk stratification analysis based on EBV DNA.
Eur J Cancer
; 159: 133-143, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34743068
9.
Geriatric nutritional risk index as an independent prognostic factor in locally advanced nasopharyngeal carcinoma treated using radical concurrent chemoradiotherapy: a retrospective cohort study.
Ann Transl Med
; 9(7): 532, 2021 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-33987230
10.
Development and validation of a normal tissue complication probability model for acquired nasal cavity stenosis and atresia after radical radiotherapy for nasopharyngeal carcinoma.
Radiother Oncol
; 160: 9-17, 2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-33839205
11.
Efficacy of Transnasal Endoscopic Fine-Needle Aspiration Biopsy in Diagnosing Submucosal Nasopharyngeal Carcinoma.
Laryngoscope
; 131(8): 1798-1804, 2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-33616259